Biomarkers for Diagnosis and Prediction of Outcomes in Contrast-Induced Nephropathy

Background. Serum creatinine is suboptimal as a biomarker in the early diagnosis of contrast-induced nephropathy (CIN). In this study, we investigated a panel of novel biomarkers in the early diagnosis of CIN and in assessing patient outcomes. Methods. This single-centre, nested, prospective case-co...

Full description

Saved in:
Bibliographic Details
Main Authors: Justor Banda, Raquel Duarte, Therese Dix-Peek, Caroline Dickens, Pravin Manga, Saraladevi Naicker
Format: Article
Language:English
Published: Wiley 2020-01-01
Series:International Journal of Nephrology
Online Access:http://dx.doi.org/10.1155/2020/8568139
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1832565989412175872
author Justor Banda
Raquel Duarte
Therese Dix-Peek
Caroline Dickens
Pravin Manga
Saraladevi Naicker
author_facet Justor Banda
Raquel Duarte
Therese Dix-Peek
Caroline Dickens
Pravin Manga
Saraladevi Naicker
author_sort Justor Banda
collection DOAJ
description Background. Serum creatinine is suboptimal as a biomarker in the early diagnosis of contrast-induced nephropathy (CIN). In this study, we investigated a panel of novel biomarkers in the early diagnosis of CIN and in assessing patient outcomes. Methods. This single-centre, nested, prospective case-controlled study included 30 patients with CIN and 60 matched controls. Serum and urine samples were collected before contrast administration and at 24 hours, 48 hours, and ≥5 days after contrast administration. Concentrations of NGAL, cystatin C, β2M, IL18, IL10, KIM1, and TNFα were determined using Luminex and ELISA assays. Outcomes were biomarker diagnostic discrimination performance for CIN and mortality after generation of area under receiver operating characteristic curves (AUROCs). Results. Median serum levels for 24 h cystatin C (p<0.01) and 48 h β2M levels (p<0.001) and baseline urine NGAL (p=0.02) were higher in CIN patients compared to controls with AUROCs of 0.75, 0.78, and 0.74, respectively, for the early diagnosis of CIN. Serum β2M levels were higher in CIN patients at all time points. Elevated baseline serum concentrations of IL18 (p<0.001), β2M (p=0.04), TNFα (p<0.001), and baseline urine KIM (p=0.01) and 24 h urine NGAL (p=0.02) were significantly associated with mortality. Baseline serum concentrations of IL18, β2M, and TNFα showed the best discrimination performance for mortality with AUROCs, all >0.80. Baseline NGAL was superior for excluding patients at risk for CIN, with positive and negative predictive ranges of 0.50–0.55 and 0.81–0.88, respectively. Cystatin C (p=0.003) and β2M (p=0.03) at 24 h independently predicted CIN risk. β2M predicted increased mortality of 40% at baseline and 50% at 24 hours. Conclusion. Serum cystatin C at 24 h was the best biomarker for CIN diagnosis, while baseline levels of serum IL18, β2M, and TNFα were best for predicting prognosis.
format Article
id doaj-art-455c7387838c4dcda775a1337f83f0b8
institution Kabale University
issn 2090-214X
2090-2158
language English
publishDate 2020-01-01
publisher Wiley
record_format Article
series International Journal of Nephrology
spelling doaj-art-455c7387838c4dcda775a1337f83f0b82025-02-03T01:05:24ZengWileyInternational Journal of Nephrology2090-214X2090-21582020-01-01202010.1155/2020/85681398568139Biomarkers for Diagnosis and Prediction of Outcomes in Contrast-Induced NephropathyJustor Banda0Raquel Duarte1Therese Dix-Peek2Caroline Dickens3Pravin Manga4Saraladevi Naicker5Department of Internal Medicine, Faculty of Health Sciences, University of the Witwatersrand, Johannesburg, South AfricaDepartment of Internal Medicine, Faculty of Health Sciences, University of the Witwatersrand, Johannesburg, South AfricaDepartment of Internal Medicine, Faculty of Health Sciences, University of the Witwatersrand, Johannesburg, South AfricaDepartment of Internal Medicine, Faculty of Health Sciences, University of the Witwatersrand, Johannesburg, South AfricaDivision of Cardiology, Charlotte Maxeke Johannesburg Academic Hospital, Johannesburg, South AfricaDepartment of Internal Medicine, Faculty of Health Sciences, University of the Witwatersrand, Johannesburg, South AfricaBackground. Serum creatinine is suboptimal as a biomarker in the early diagnosis of contrast-induced nephropathy (CIN). In this study, we investigated a panel of novel biomarkers in the early diagnosis of CIN and in assessing patient outcomes. Methods. This single-centre, nested, prospective case-controlled study included 30 patients with CIN and 60 matched controls. Serum and urine samples were collected before contrast administration and at 24 hours, 48 hours, and ≥5 days after contrast administration. Concentrations of NGAL, cystatin C, β2M, IL18, IL10, KIM1, and TNFα were determined using Luminex and ELISA assays. Outcomes were biomarker diagnostic discrimination performance for CIN and mortality after generation of area under receiver operating characteristic curves (AUROCs). Results. Median serum levels for 24 h cystatin C (p<0.01) and 48 h β2M levels (p<0.001) and baseline urine NGAL (p=0.02) were higher in CIN patients compared to controls with AUROCs of 0.75, 0.78, and 0.74, respectively, for the early diagnosis of CIN. Serum β2M levels were higher in CIN patients at all time points. Elevated baseline serum concentrations of IL18 (p<0.001), β2M (p=0.04), TNFα (p<0.001), and baseline urine KIM (p=0.01) and 24 h urine NGAL (p=0.02) were significantly associated with mortality. Baseline serum concentrations of IL18, β2M, and TNFα showed the best discrimination performance for mortality with AUROCs, all >0.80. Baseline NGAL was superior for excluding patients at risk for CIN, with positive and negative predictive ranges of 0.50–0.55 and 0.81–0.88, respectively. Cystatin C (p=0.003) and β2M (p=0.03) at 24 h independently predicted CIN risk. β2M predicted increased mortality of 40% at baseline and 50% at 24 hours. Conclusion. Serum cystatin C at 24 h was the best biomarker for CIN diagnosis, while baseline levels of serum IL18, β2M, and TNFα were best for predicting prognosis.http://dx.doi.org/10.1155/2020/8568139
spellingShingle Justor Banda
Raquel Duarte
Therese Dix-Peek
Caroline Dickens
Pravin Manga
Saraladevi Naicker
Biomarkers for Diagnosis and Prediction of Outcomes in Contrast-Induced Nephropathy
International Journal of Nephrology
title Biomarkers for Diagnosis and Prediction of Outcomes in Contrast-Induced Nephropathy
title_full Biomarkers for Diagnosis and Prediction of Outcomes in Contrast-Induced Nephropathy
title_fullStr Biomarkers for Diagnosis and Prediction of Outcomes in Contrast-Induced Nephropathy
title_full_unstemmed Biomarkers for Diagnosis and Prediction of Outcomes in Contrast-Induced Nephropathy
title_short Biomarkers for Diagnosis and Prediction of Outcomes in Contrast-Induced Nephropathy
title_sort biomarkers for diagnosis and prediction of outcomes in contrast induced nephropathy
url http://dx.doi.org/10.1155/2020/8568139
work_keys_str_mv AT justorbanda biomarkersfordiagnosisandpredictionofoutcomesincontrastinducednephropathy
AT raquelduarte biomarkersfordiagnosisandpredictionofoutcomesincontrastinducednephropathy
AT theresedixpeek biomarkersfordiagnosisandpredictionofoutcomesincontrastinducednephropathy
AT carolinedickens biomarkersfordiagnosisandpredictionofoutcomesincontrastinducednephropathy
AT pravinmanga biomarkersfordiagnosisandpredictionofoutcomesincontrastinducednephropathy
AT saraladevinaicker biomarkersfordiagnosisandpredictionofoutcomesincontrastinducednephropathy